A meta-analysis indicated that AD patients, rather than mild cognitive impairment patients, have significantly lower serum BDNF levels compared to age-matched healthy controls, and a significant decrease in peripheral BDNF levels can only be detected at the late stage of dementia (Ng et al., 2019). This evidence concerns the gene BDNF and Alzheimer disease.